Gyre Therapeutics, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Gyre Therapeutics, Inc. (GYRE) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$116.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-20.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2020-02-20
- Gyre Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was -$116.00K.
- Gyre Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2017 was -$3.00K, a 100.50% decline from fiscal 2016.
- Gyre Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2016 was $600.00K.
- Gyre Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2018-12-31 | -$116.00K 10-K · filed 2020-02-20 |
| 2017-12-31 | -$3.00K 10-K · filed 2019-03-08 |
| 2016-12-31 | $600.00K 10-K · filed 2017-03-08 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |